Many around the world are curious about the good news that would change the pandemic’s current scenario and bring back normalcy to the fore. The rule book is being rewritten quite often by the research labs and the pharmaceuticals on the estimated date or the vaccine development time. Some extraordinary steps have been taken to ensure the mass production of the vaccine goes global. But as we advance with the hope of vaccine development, there are staggering concerns that the one who produces the vaccine will be a rich country at the cost of the ones who are most vulnerable.
Questions about the vaccine’s accessibility are being asked, followed by the estimated price and how the world leaders would ensure that no one is left behind without a vaccine. Vaccines that have been the most frequently discussed topic fights infectious diseases do take a requisite amount of years to be developed, tested, and delivered, and the worse part is that its success is not guaranteed. Smallpox has been the only human infectious disease that has been eradicated, which lasted almost 200 years.
When can we expect the coronavirus vaccine?
Thousands of people have been participating in the trials to see the right vaccine against the COVID-19. A process that lasts almost a decade is being pared down to 2 months. The production is being augmented with the investors and manufacturers investing billions of dollars in producing an effective vaccine.
The Sputnik V vaccine trials of Russia have shown immune response signs in patients and have handed out this vaccine for public use while the trials for the last stage is still in process. China has confirmed a successful vaccine used by its military personnel, but there are still concerns about the speed of those vaccine productions. Some candidates expect approved vaccinations by the end of the year, despite WHO making it clear that it does not expect to see worldwide vaccinations against COVID-19 until June 2021.
Pfizer and BioNtech report the introductory analysis that a vaccine can prevent 90 percent of the people from COVID-19. They plan that they would make applications about the vaccine’s emergency usage by the end of November. Pfizer could also make supplies of 50 Million and 1.3 Billion doses by the end of 2020 and 2021.
Governments are putting their bets on the production of potential vaccines. They are making deals for multiple doses for a wide range of candidates before an official or a certified approval. The government of the United Kingdom has signed deals for a confidential amount of 6 potential COVID vaccines that may or may not be successful. The United States, from its investment program, expects doses worth 300 million in amount by the end of January 2021 to speed up the production of a successful vaccine. The WHO and the Epidemic response group, Cepi, and Gavi, the Vaccine Alliance of Governments and organizations, are working its way out to be on the same page to pursue a vaccine success. The global vaccine plan is currently signed by 94 wealthy nations, also known as Covax, which aims to raise at least 2 Billion Dollars by the end of 2020 for fair and worldwide vaccine distribution. The US, which has left ties with WHO, is not a part of this agreement.
Regarding the cost of the vaccine, billions of dollars are being invested in developing the vaccine. On the other hand, millions of dollars are invested in the supply of vaccines. Prices of vaccines will be on a per-dose basis, the kind of vaccine used by the manufacturer, and the approximate number of doses ordered. Moderna, a US-based Pharmaceutical, has also reported the prices of the potential vaccine to be sold at $32 and $37. Although the pharmaceuticals company produces the vaccines, they won’t decide who gets vaccinated first.